• No results found

Oral levosimendan in amyotrophic lateral sclerosis: A phase II multicentre, randomised, double blind, placebo controlled trial

N/A
N/A
Protected

Academic year: 2020

Share "Oral levosimendan in amyotrophic lateral sclerosis: A phase II multicentre, randomised, double blind, placebo controlled trial"

Copied!
6
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1 Baseline demographics and characteristics
Figure 2 slow vital capacity (sVc) (per cent of predicted normal) measured in the supine position

References

Related documents

Results showed that PUF60 overexpression significantly enhanced the proliferation, migration, invasion, and tumori- genesis of breast cancer cells, as well as repressed cell

Abstract:- In this paper making use of well known WP Bailey’s Pairs, an attempt has been made to established certain interesting transformation formulae for Basic

Keywords: peripheral artery disease, stent implantation, dual antiplatelet therapy, primary patency, endovascular

This paper proposes the Reversible texture synthesis for data security. The source texture is given and the scheme produces the stego synthetic texture can hiding the secret

We found that the ELBW/very preterm cohort exhibited significant deficits across all cognitive parameters assessed, whereas their behavioral impairments were restricted mainly to

The benefits of vehicle separation are found to depend on several factors: the relative volumes of cars and trucks, the congestion delay and safety hazards that each type of

Our objective was to examine the effects of the con- tinuous support provided by doulas on the method of delivery, use of epidural anesthesia, and use of oxytocin during labour

Differences in the concentrations of serum IgM, IgA, and IgG, antibodies to GXM, and idiotype titers between groups (i.e., C. neoformans -negative group for pre- and post-